If you’re one of the 8 million American women with osteoporosis, your doctor has probably talked to you about treatment options to slow the disease’s progression and keep your bones in tip-top shape.

A new study says more people taking Fosamax (alendronate) might be at risk for developing major problems with their jaws than scientists believed before, according to findings published in the latest ...

Two recent reports have linked the osteoporosis drug alendronate (Fosamax) with rare but serious side effects. In a letter to the New England Journal of Medicine published Jan. 1, a Food and Drug ...

We eat healthy and exercise as regularly as we can to stay strong and ward off osteoporosis-but should the prescription drug Fosamax be part of our bone-boosting arsenal? Keep reading for a top ...

Sept 20 (Reuters) - A U.S. appeals court on Friday revived more than 500 lawsuits alleging that Merck & Co (MRK.N), opens new tab failed to warn that its osteoporosis drug Fosamax increased the risk ...

DEAR DR. ROACH: My primary care doctor has prescribed the medication Evenity for my osteoporosis. I have been on Fosamax for about three years, but my recent bone density scan went down slightly in ...

A confidential agreement has been reached in a lawsuit filed against Merck, maker of the osteoporosis drug Fosamax, by a woman who claimed she suffered from Fosamax-related damages to her jaw. The ...

SEATTLE—Women who have used Fosamax are nearly twice as likely to develop the most common kind of chronically irregular heartbeat (atrial fibrillation) than are those who have never used it, according ...

In the United States, the safety of prescription drugs is overseen along two parallel pathways. Federal regulation is provided by the Food and Drug Administration (FDA), which works to ensure the ...

Merck & Co., already battered by Vioxx lawsuits, is preparing for a blizzard of litigation from patients claiming they were harmed by Fosamax, the company's hot-selling osteoporosis drug. The ...

WHITEHOUSE STATION, N.J., Oct. 4, 2010 - Merck & Co., Inc. today said it will appeal a decision by the U.S. District Court for the Southern District of New York that reduced the jury verdict from $8 ...

The U.S. Supreme Court on Monday denied a petition for a writ of certiorari filed by the drug company Merck Sharp & Dohme Corp., bringing to a close a decade-long legal battle that had stalled ...